Metabolon offers metabolomics services and products, including biomarker discovery and targeted metabolomics analysis. The company provides solutions for various applications such as drug development, precision medicine, and population health studies.

Metabolon

Molecular You offers preventive health assessments and lifestyle coaching, analyzing unique blood profiles to provide health insights.

Molecular You

Shift Bioscience focuses on simulation guided cell rejuvenation to address diseases related to aging. The company has developed a platform that discovers gene-based interventions to rejuvenate cells without inducing stem cell identity.

Shift Bioscience

Almost every factor that affects health – from genetics and the microbiome to disease and lifestyle – exerts its influence by altering metabolite levels in the body or other biological system. By producing the most accurate and comprehensive picture of the collection of metabolites, known as the metabolome, from a single biological sample, Metabolon can deliver an instantaneous snapshot of the entire physiology of a living being at a discreet point in time, as well as identify changes in that system brought about the impact of disease, medical intervention, diet or the environment.  This deep and comprehensive view of the metabolome provides  biological insights that cannot be revealed through any other research methodology, enabling life sciences researchers and drug developers to discover answers some of biology’s most difficult questions.

Metabolon's unrivaled capability to look deep into the metabolome has enabled us to build the world’s largest library of compounds that currently includes 5,200+ total known molecules.  Our proprietary Precision Metabolomics™ platform, combined with the world's most experienced metabolomics scientists, delivers biologic insights and identification of novel commercial opportunities for drug discovery and development, through clinical trials and life cycle management. Metabolon’s expertise is also accelerating research and product development for clients in academia, population health, consumer products, and nutrition industries. 

Founded in 2000 and based in Research Triangle Park, North Carolina, Metabolon has conducted more than 10,000 independent and collaborative studies, resulting in 2,000+ publications in leading peer-reviewed journals. For more information about our technology, products and services, please visit www.metabolon.com.

Essex Woodlands Healthcare Partners

Perceptive Advisors

The Aurora Funds

Fletcher Spaght, Inc.

Sumitomo

Syngenta Ventures

Fulcrum Equity Partners

Camden Partners

180 Degree Capital

EW Healthcare Partners

Metabolon, Inc.

At Metabolon, we believe that Purpose is the compass that guides us towards making a real impact. Purpose isn't just a lofty ideal for us – it's the heartbeat of every decision we make.  

Hear from Annie Evans, Senior Director, Head of Core Research at Metabolon about what Purpose means to her. Interested in joining us?  Check out our open positions here: https://lnkd.in/eAKtpmZV  

#PowerofPurpose #MetabolonLife #WorkatMetabolon #CompanyCulture #PurposePassionPerformance #MissionDriven #CompanyValues 

January is #CervicalHealthAwarenessMonth and a time to bring awareness to #cervical #health and cervical cancer prevention. 

>>>Learn more about how Metabolon is committed to further research into targeted therapeutic interventions for cervical cancer: https://bit.ly/48MTEed

The publication explores the complex interplay between #immunometabolic alterations and potential tumor-promoting changes in 3D #cervicalcancer models. Metabolon played a pivotal role in contributing comprehensive #metabolomic #data, providing detailed insights into the #metabolic landscape associated with the 3D cervical cancer microenvironment. Through advanced metabolomic profiling, Metabolon's contribution enhanced the understanding of the intricate relationships between immune responses and metabolic changes in the context of cervical cancer.

#multiomics #omics #biomarkers #biochemistry #phenotype

NEW CASE STUDY! Utilizing a comprehensive #metabolomic profiling approach, this study investigates the potential of #metabolomics in identifying #metabolic markers associated with blood pressure regulation. The findings reveal a set of #metabolites exhibiting significant correlation with blood pressure, highlighting their potential utility as #biomarkers for monitoring and understanding blood pressure dynamics. This research underscores the power of metabolomics in uncovering novel insights into #cardiovascular #health and provides a foundation for future studies exploring the intricate interplay between metabolites and blood pressure regulation.

>>>Access the full case study here for in-depth insights into the methodology and outcomes of this impactful investigation: https://bit.ly/3SeZakw

#multiomics #omics #biochemistry #phenotype #phenotyping

Discover how advances in high-resolution mass spectrometry and access to reliable, reproducible metabolomics data are enabling biopharma projects to progress faster and achieve clinical success more reliably than ever before!

Download this free compendium to explore the role #metabolomics plays in biopharma workflows, the value metabolomics brings to bioprocessing, and how introducing metabolomics into a multi-omics model of drug discovery and drug development can lead to new insights not possible without getting closer to the phenotype.

📘 https://mtbln.co/0v437v

#Metabolon #massspec #biopharma #drugdiscovery


Happy New Year!  Looking to unlock the power of #metabolomics in 2024? Dive into the world of metabolomics studies and discover the five key elements that drive groundbreaking insights into biological systems. From sample collection to advanced analytics, this blog post breaks down the essentials for a successful metabolomics study. Whether you're new to the field or a seasoned researcher, this blog provides valuable insights to enhance your understanding and proficiency in metabolomics. Read more at:  https://bit.ly/47qfDq2

#multiomics #omics #biomarkers #biomarkerdiscovery #biochemistry #phenotype #research #scientificinsights

Metric
Company Name	Metabolon	Molecular You	Shift Bioscience
Symbol
MSH ID	COM:METABOLON	COM:MOLECULARYOU	COM:SHIFTBIOSCIENCE
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Biotechnology	Health Technology	Biotechnology
Country	US	CA	GB
Stage
Employee Count	268
Website	metabolon.com	molecularyou.com	shiftbioscience.com
LinkedIn
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:METABOLON

Metabolon

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue